Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas

Noninvasive molecular biomarkers for the detection of colorectal cancer

(2011) Hye-Jung Kim et al.   BMB Reports

High-mobility group box 1 and cancer

(2010) Daolin Tang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Analysis of Nuclear High Mobility Group Box 1 (HMGB1)-Binding Proteins in Colon Cancer Cells: Clustering with Proteins Involved in Secretion and Extranuclear Function

(2010) Hanna Lee et al.   JOURNAL OF PROTEOME RESEARCH

Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity

(2009) M. Candolfi et al.   CLINICAL CANCER RESEARCH

Clinical Value of Serum HMGB1 Levels in Early Detection of Recurrent Squamous Cell Carcinoma of Uterine Cervix: Comparison with Serum SCCA, CYFRA21-1, and CEA Levels

(2009) Xiugui Sheng et al.   CROATIAN MEDICAL JOURNAL

Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.

(2009) Wojciech Naumnik et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma

(2009) Xingjun Yao et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

(2009) Hye Chung et al.   Journal of Translational Medicine

Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers

(2009) Hyun Ju Kang et al.   LABORATORY INVESTIGATION

Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer

(2009) Guan-Hong Shang et al.   RESPIRATORY MEDICINE

Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma

(2008) B.-Q. Cheng et al.   DIGESTIVE AND LIVER DISEASE